American Diabetes Association Overview

A comprehensive set of guidelines for managing diabetes, updated annually.

A professional organization dedicated to improving the lives of people with diabetes.

The year in which the Standards of Care in Diabetes document was published.

A website dedicated to publishing information about diabetes.

The official journal where the Standards of Care in Diabetes is published.

A yearly update of the Standards of Care in Diabetes, published alongside the main document.

The volume number of the journal where the Standards of Care in Diabetes is published.

The international standard serial number that identifies the Standards of Care in Diabetes document.

The American Diabetes Association is a professional organization dedicated to preventing and curing diabetes. They also work to improve the lives of everyone affected by the condition.

These guidelines are updated annually and published in the "Journal of Clinical and Applied Research and Education".

The official journal where the Standards of Care in Diabetes is published.

The ADA publishes a supplement each year that contains updated information for the Standards of Care in Diabetes.

You can find the Standards of Care in Diabetes on the ADA's website at DiabetesJournals.org/CARE.

The ISSN, or International Standard Serial Number, is a unique identifier for publications. It's like a digital barcode.

The volume number of the journal where the Standards of Care in Diabetes is published.

The year the Standards of Care in Diabetes document was published.

A chronic condition requiring continuous medical care and management.

The process of regularly monitoring and managing blood glucose levels.

A website dedicated to providing resources specifically for healthcare professionals.

A rating system used to assess the strength of evidence supporting recommendations in the Standards of Care, ranging from A (strongest) to C (weakest).

Randomized controlled trials (RCTs) or meta-analysis of RCTs that provide strong evidence for a recommendation.

Involves reviewing all relevant research to form recommendations. This includes systematically searching for evidence, evaluating study quality, and summarizing key findings.

Guidelines used to treat diabetes, based on the best available evidence and consensus among experts. These guidelines are updated annually.

Experts in a specific field who participate in the development of Standards of Care.

Using multiple forms of evidence to inform clinical decisions and recommendations.

A collaborative team involving doctors, researchers, and other professionals working together to develop and update Standards of Care.

The process of carefully reviewing and revising drafts of the Standards of Care document, ensuring accuracy and consensus.

A formal document that summarizes current evidence and consensus opinions on a specific medical or scientific topic, particularly when the evidence is uncertain or conflicting.

The official journal of the American Diabetes Association, where the Standards of Care in Diabetes document is published.

A unique numerical identifier used to recognize publications, similar to a barcode for information.

This recommendation emphasizes the importance of regular dental checkups for people with diabetes, especially those with poor glycemic control. It encourages coordinated care between medical and dental teams to address potential complications.

This updated recommendation highlights the critical role of sleep in managing prediabetes and type 2 diabetes, putting it on the same level as other lifestyle factors like exercise and diet.

This recommendation discusses the use of vitamin D therapy for diabetes prevention. It emphasizes the importance of considering long-term effects of metformin on vitamin B12 levels.

This updated guideline suggests that individuals with type 2 diabetes should have their disability status assessed at their initial visit, and their functional decline should be monitored at subsequent visits.

This recommendation highlights the importance of coordinating between medical and dental teams to ensure proper adjustment of glucose-lowering medications before and after dental procedures.

This revised recommendation proposes using a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptor agonist (RA) as an adjunctive therapy for weight loss in people with type 2 diabetes.

The revised recommendation states that individuals with type 2 diabetes and biopsy-proven MASH, or those with the condition but lacking biopsy confirmation, should both be considered for this dual RA therapy.

This recommendation underscores the need for structured nutrition and physical activity plans to achieve cardiometabolic benefits and histological improvement.